Dopo l'orario di chiusura: 308.45

AMGEN Inc. (AMGN)

AMGEN Inc. Borsa (AMGN) Ultime notizie

AMGEN Inc. (AMGN)

AMGEN Inc. Borsa (AMGN) Ultime notizie

Best Inverse/Leveraged ETFs of Last Week

The Zacks Analyst Blog Highlights Amgen, Amazon.com, Apple, Boeing and Goldman Sachs

My Dividend Growth Portfolio: Selling Bio-Pharma And Buying More Big-Tech

Amgen Is Working On a Wegovy Competitor -- What It Means for Investors

5 Stocks Driving Dow's Market-Beating Performance

Wall Street Stares At Weaker Open On Rate Anxiety, Hopes For Better Earnings: Analyst Pencils Key S&P 500 Support Level

3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Company News for May 6, 2024

Cathie Wood's Ark Invest Snaps Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline Update

SCHD: A Must-Have In Every Dividend Portfolio

Why Amgen Stock Zoomed Nearly 12% Higher Today

Stocks Rally As Jobs Report Rekindles Rate Cut Hopes, Apple Rockets, Bitcoin Soars Above $61,000: What's Driving Markets Friday?

Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update

Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value

Wage Growth Slows – Stock Market Celebrates, Five Real Reasons Apple Is Running Up

Wall Street Looks To Feed Off Apple's Post-Earnings Power But Key Jobs Data May Upset The Cart: Analyst Says 'A Lot Of These Clouds Will Lift' If This Happens

Here's What Key Metrics Tell Us About Amgen (AMGN) Q1 Earnings

Wall Street Inches Up After Powell's Inflation Remarks; Chipmakers Rebound; Gold, Crude Falter: What's Driving Markets Thursday?

Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market

Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?

What's in the Cards for Amgen (AMGN) This Earnings Season?

Insights Into Amgen (AMGN) Q1: Wall Street Projections for Key Metrics

3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income

Wall Street Breakfast: The Week Ahead

AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up

Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for

Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?

Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?

Better Buy: Pfizer vs. Viking Therapeutics

1 No-Brainer Vanguard Fund to Buy Right Now

Why Amgen (AMGN) Outpaced the Stock Market Today

Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks

SCHD: If You've Won The Game, Take A Little Off The Top

Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies

Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights

Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick

Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday

Can This High-Yield Dividend Stock Keep Beating the S&P 500?

Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever

Should You Invest in the VanEck Biotech ETF (BBH)?

Amgen (AMGN) Laps the Stock Market: Here's Why

Is Amgen Stock a Buy?

Rose's Income Garden Portfolio With 7 March Dividend Raises/ Portfolio Yield 6%

Biophytis (BPTS) to Begin Phase II Obesity Study, Stock Up

3 Top Dividend Stocks to Maximize Your Retirement Income

2 Biotech Stocks to Buy Hand Over Fist in April

Amgen (AMGN) Ascends But Remains Behind Market: Some Facts to Note

Building A $1.4 Million Retirement Fund: 4 Stocks Yielding Up To 6% To Get The Job Done

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Simile a AMGN